Literature DB >> 11758776

Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol 934P.

M Thanou1, J C Verhoef, M T Nihot, J H Verheijden, H E Junginger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11758776     DOI： 10.1023/a:1013055120007

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  12 in total

Review 1.  Low-molecular-weight heparin: biochemistry, pharmacology, and concurrent drug precautions.

Authors:  J A Heit
Journal:  Reg Anesth Pain Med       Date:  1998 Nov-Dec       Impact factor: 6.288

2.  Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.

Authors:  M Thanou; J C Verhoef; J H Verheijden; H E Junginger
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 3.  Monitoring of low-molecular-weight heparins in cardiovascular disease.

Authors:  R Abbate; A M Gori; A Farsi; M Attanasio; G Pepe
Journal:  Am J Cardiol       Date:  1998-09-10       Impact factor: 2.778

4.  Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers.

Authors:  D Brayden; E Creed; A O'Connell; H Leipold; R Agarwal; A Leone-Bay
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

5.  Treatment of experimentally induced caval thrombosis with oral low molecular weight heparin and delivery agent in a porcine model of deep venous thrombosis.

Authors:  K Salartash; M Lepore; M D Gonze; A Leone-Bay; R Baughman; W C Sternbergh; J C Bowen; S R Money
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

6.  Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat.

Authors:  K Salartash; M D Gonze; A Leone-Bay; R Baughman; W C Sternbergh; S R Money
Journal:  J Vasc Surg       Date:  1999-09       Impact factor: 4.268

7.  Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.

Authors:  H L Luessen; B J de Leeuw; M W Langemeÿer; A B de Boer; J C Verhoef; H E Junginger
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

Review 8.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Authors:  J Hirsh; T E Warkentin; R Raschke; C Granger; E M Ohman; J E Dalen
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

9.  Acylated non-alpha-amino acids as novel agents for the oral delivery of heparin sodium, USP.

Authors:  A Leone-Bay; D R Paton; B Variano; H Leipold; T Rivera; J Miura-Fraboni; R A Baughman; N Santiago
Journal:  J Control Release       Date:  1998-01-02       Impact factor: 9.776

10.  Relationship between plasma antifactor Xa activity and the antithrombotic activity of heparins of different molecular mass.

Authors:  P Bianchini; G L Bergonzini; B Parma; B Osima
Journal:  Haemostasis       Date:  1995 Nov-Dec
View more
  5 in total

1.  Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation.

Authors:  Nusrat Abbas Motlekar; Kalkunte Srirangachar Srivenugopal; Mitchell S Wachtel; Bi-Botti Celestin Youan
Journal:  J Pharm Pharmacol       Date:  2006-05       Impact factor: 3.765

Review 2.  The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.

Authors:  Nusrat A Motlekar; Bi-Botti C Youan
Journal:  J Control Release       Date:  2006-06-14       Impact factor: 9.776

3.  Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.

Authors:  Nusrat A Motlekar; Alessio Fasano; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  J Drug Target       Date:  2006-06       Impact factor: 5.121

4.  Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.

Authors:  Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  Drug Dev Res       Date:  2006-02       Impact factor: 4.360

Review 5.  Strategies to Overcome Heparins' Low Oral Bioavailability.

Authors:  Ana Rita Neves; Marta Correia-da-Silva; Emília Sousa; Madalena Pinto
Journal:  Pharmaceuticals (Basel)       Date:  2016-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.